86 related articles for article (PubMed ID: 8787838)
1. Role of cholecystokinin-B receptor in the maintenance of thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat.
Yamamoto T; Nozaki-Taguchi N
Neurosci Lett; 1995 Dec; 202(1-2):89-92. PubMed ID: 8787838
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat.
Yamamoto T; Sakashita Y
Anesthesiology; 1999 May; 90(5):1382-91. PubMed ID: 10319787
[TBL] [Abstract][Full Text] [Related]
3. The effects of intrathecally administered FK480, a cholecystokinin-A receptor antagonist, and YM022, a cholecystokinin-B receptor antagonist, on the formalin test in the rat.
Yamamoto T; Nozaki-Taguchi N
Anesth Analg; 1996 Jul; 83(1):107-13. PubMed ID: 8659718
[TBL] [Abstract][Full Text] [Related]
4. Effects of intrathecally administered nociceptin, an opioid receptor-like1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat.
Yamamoto T; Nozaki-Taguchi N; Kimura S
Neurosci Lett; 1997 Mar; 224(2):107-10. PubMed ID: 9086468
[TBL] [Abstract][Full Text] [Related]
5. Effects of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, and N-methyl-D-aspartate receptor antagonists on the thermal hyperalgesia induced by partial sciatic nerve injury in the rat.
Yamamoto T; Nozaki-Taguchi N
Anesthesiology; 1997 Nov; 87(5):1145-52. PubMed ID: 9366467
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy.
Mao J; Price DD; Hayes RL; Lu J; Mayer DJ
Brain Res; 1992 Dec; 598(1-2):271-8. PubMed ID: 1362520
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of opioidergic systems in the antinociceptive effect of the selective serotonin reuptake inhibitors in sciatic nerve-injured mice.
Nozaki C; Kamei J
Eur J Pharmacol; 2006 Dec; 552(1-3):99-104. PubMed ID: 17056034
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent effect of morphine and time-independent effect of MK-801, an NMDA antagonist, on the thermal hyperesthesia induced by unilateral constriction injury to the sciatic nerve in the rat.
Yamamoto T; Shimoyama N; Asano H; Mizuguchi T
Anesthesiology; 1994 Jun; 80(6):1311-9. PubMed ID: 8010478
[TBL] [Abstract][Full Text] [Related]
9. In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics.
Idänpään-Heikkilä JJ; Perrot S; Guilbaud G; Kayser V
Eur J Pharmacol; 1997 May; 325(2-3):155-64. PubMed ID: 9163562
[TBL] [Abstract][Full Text] [Related]
10. SYM-2081 a kainate receptor antagonist reduces allodynia and hyperalgesia in a freeze injury model of neuropathic pain.
Ta LE; Dionne RA; Fricton JR; Hodges JS; Kajander KC
Brain Res; 2000 Mar; 858(1):106-20. PubMed ID: 10700603
[TBL] [Abstract][Full Text] [Related]
11. Clonidine, but not morphine, delays the development of thermal hyperesthesia induced by sciatic nerve constriction injury in the rat.
Yamamoto T; Nozaki-Taguchi N
Anesthesiology; 1996 Oct; 85(4):835-45. PubMed ID: 8873554
[TBL] [Abstract][Full Text] [Related]
12. The role of spinal cholecystokinin B receptors in thermal allodynia and hyperalgesia in diabetic mice.
Kamei J; Zushida K
Brain Res; 2001 Feb; 892(2):370-5. PubMed ID: 11172785
[TBL] [Abstract][Full Text] [Related]
13. Exogenous melatonin abolishes mechanical allodynia but not thermal hyperalgesia in neuropathic pain. The role of the opioid system and benzodiazepine-gabaergic mechanism.
Zurowski D; Nowak L; Machowska A; Wordliczek J; Thor PJ
J Physiol Pharmacol; 2012 Dec; 63(6):641-7. PubMed ID: 23388480
[TBL] [Abstract][Full Text] [Related]
14. Effects of pre-emptively administered nociceptin on the development of thermal hyperalgesia induced by two models of experimental mononeuropathy in the rat.
Yamamoto T; Ohtori S; Chiba T
Brain Res; 2000 Jul; 871(2):192-200. PubMed ID: 10899286
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the CCK2 receptor gene reduces mechanical sensitivity and abolishes the development of hyperalgesia in mononeuropathic mice.
Kurrikoff K; Kõks S; Matsui T; Bourin M; Arend A; Aunapuu M; Vasar E
Eur J Neurosci; 2004 Sep; 20(6):1577-86. PubMed ID: 15355324
[TBL] [Abstract][Full Text] [Related]
16. Rapid development of nitric oxide-induced hyperalgesia depends on an alternate to the cGMP-mediated pathway in the rat neuropathic pain model.
Inoue T; Mashimo T; Shibata M; Shibuta S; Yoshiya I
Brain Res; 1998 May; 792(2):263-70. PubMed ID: 9593928
[TBL] [Abstract][Full Text] [Related]
17. Lithium attenuates pain-related behavior in a rat model of neuropathic pain: possible involvement of opioid system.
Banafshe HR; Mesdaghinia A; Arani MN; Ramezani MH; Heydari A; Hamidi GA
Pharmacol Biochem Behav; 2012 Jan; 100(3):425-30. PubMed ID: 22009032
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal ultra-low dose naloxone enhances the antihyperalgesic effects of morphine and attenuates tumor necrosis factor-α and tumor necrosis factor-α receptor 1 expression in the dorsal horn of rats with partial sciatic nerve transection.
Yang CP; Cherng CH; Wu CT; Huang HY; Tao PL; Lee SO; Wong CS
Anesth Analg; 2013 Dec; 117(6):1493-502. PubMed ID: 24257399
[TBL] [Abstract][Full Text] [Related]
19. Anti-analgesia and reduced antinociception from supraspinally administered beta-endorphin in stressed rats: dependence on spinal cholecystokinin via cholecystokinin B receptors.
Hawranko AA; Serafini M; Smith DJ
Neurosci Lett; 1999 May; 267(2):101-4. PubMed ID: 10400222
[TBL] [Abstract][Full Text] [Related]
20. Respective pharmacological features of neuropathic-like pain evoked by intrathecal BDNF versus sciatic nerve ligation in rats.
M'Dahoma S; Barthélemy S; Tromilin C; Jeanson T; Viguier F; Michot B; Pezet S; Hamon M; Bourgoin S
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2118-30. PubMed ID: 26343858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
